FDA Approves First-Ever Drug for Treating Postpartum Depression

For most new mothers, life with a newborn is a sleeplessly wonderful thing. But for one in nine women in the U.S. suffering from postpartum depression, those months of baby bliss can be anything but.

Postpartum depression is more than just a case of the “baby blues.” Symptoms often include an intense sadness, depressed mood, difficulty bonding with your baby, crippling anxiety and anger, fear that you’re not a good mother, and thoughts of harming yourself or the baby, among other things.

For years, doctors and medical professionals have been treating postpartum depression with the same drugs used to treat depression symptoms among the general public. But postpartum depression is different. It’s often triggered or caused by hormonal changes that women experience after pregnancy — something that selective serotonin reuptake inhibitors can’t specifically target.

Bri Lamm
Bri Lamm
Bri Lamm is the Editor of foreverymom.com. An outgoing introvert with a heart that beats for adventure, she lives to serve the Lord, experience the world, and eat macaroni and cheese all while capturing life’s greatest moments on one of her favorite cameras. Follow her on Facebook.

Related Posts


Recent Stories